Mucopolysaccharidosis and Autophagy: Controversies on the Contribution of the Process to the Pathogenesis and Possible Therapeutic Applications

Mucopolysaccharidosis (MPS) consists of a group of 11 enzymatic defects which result in accumulation of undegraded glycosaminoglycans (GAG) in lysosomes. MPS is a severe metabolic disease for which only bone marrow/hematopoietic stem cell transplantation and enzyme replacement therapy are current th...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierzynowska, Karolina, Gaffke, Lidia, Podlacha, Magdalena, Brokowska, Joanna, Węgrzyn, Grzegorz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021662/
https://www.ncbi.nlm.nih.gov/pubmed/31372809
http://dx.doi.org/10.1007/s12017-019-08559-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021662/
https://www.ncbi.nlm.nih.gov/pubmed/31372809
http://dx.doi.org/10.1007/s12017-019-08559-1

Ejemplares similares